[go: up one dir, main page]

NO20032048L - Fremgangsmåte for fremstilling av latent antitrombin III - Google Patents

Fremgangsmåte for fremstilling av latent antitrombin III

Info

Publication number
NO20032048L
NO20032048L NO20032048A NO20032048A NO20032048L NO 20032048 L NO20032048 L NO 20032048L NO 20032048 A NO20032048 A NO 20032048A NO 20032048 A NO20032048 A NO 20032048A NO 20032048 L NO20032048 L NO 20032048L
Authority
NO
Norway
Prior art keywords
preparation
antithrombin iii
latent antithrombin
latent
iii
Prior art date
Application number
NO20032048A
Other languages
English (en)
Other versions
NO20032048D0 (no
Inventor
Goeran Karlsson
Original Assignee
Octapharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SE0004086A external-priority patent/SE0004086D0/xx
Application filed by Octapharma Ag filed Critical Octapharma Ag
Publication of NO20032048L publication Critical patent/NO20032048L/no
Publication of NO20032048D0 publication Critical patent/NO20032048D0/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
    • C07K14/8121—Serpins
    • C07K14/8128—Antithrombin III
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Neurology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Rheumatology (AREA)
  • Hospice & Palliative Care (AREA)
  • Diabetes (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Microbiology (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
NO20032048A 2000-11-08 2003-05-07 Fremgangsmåte for fremstilling av latent antitrombin III NO20032048D0 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE0004086A SE0004086D0 (sv) 2000-11-08 2000-11-08 Preparation process
US25214800P 2000-11-20 2000-11-20
PCT/SE2001/002473 WO2002038610A1 (en) 2000-11-08 2001-11-08 Process for the preparation of latent antithrombin iii

Publications (2)

Publication Number Publication Date
NO20032048L true NO20032048L (no) 2003-05-07
NO20032048D0 NO20032048D0 (no) 2003-05-07

Family

ID=26655296

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20032048A NO20032048D0 (no) 2000-11-08 2003-05-07 Fremgangsmåte for fremstilling av latent antitrombin III

Country Status (15)

Country Link
EP (1) EP1332159A1 (no)
JP (1) JP2004522707A (no)
KR (1) KR20030057545A (no)
AU (1) AU2002214468A1 (no)
BR (1) BR0115188A (no)
CA (1) CA2428055A1 (no)
CZ (1) CZ20031277A3 (no)
EE (1) EE200300218A (no)
HU (1) HUP0301766A3 (no)
IL (1) IL155539A0 (no)
MX (1) MXPA03004030A (no)
NO (1) NO20032048D0 (no)
PL (1) PL360410A1 (no)
RU (1) RU2003117016A (no)
WO (1) WO2002038610A1 (no)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7832566B2 (en) 2002-05-24 2010-11-16 Biomet Biologics, Llc Method and apparatus for separating and concentrating a component from a multi-component material including macroparticles
US20030205538A1 (en) 2002-05-03 2003-11-06 Randel Dorian Methods and apparatus for isolating platelets from blood
US7845499B2 (en) 2002-05-24 2010-12-07 Biomet Biologics, Llc Apparatus and method for separating and concentrating fluids containing multiple components
US20060278588A1 (en) 2002-05-24 2006-12-14 Woodell-May Jennifer E Apparatus and method for separating and concentrating fluids containing multiple components
SE0203770D0 (sv) * 2002-12-19 2002-12-19 Biovitrum Ab Method of separation
JP4510898B2 (ja) 2005-02-07 2010-07-28 ハヌマン リミテッド ライアビリティ カンパニー 血漿濃縮装置
US7694828B2 (en) 2005-04-27 2010-04-13 Biomet Manufacturing Corp. Method and apparatus for producing autologous clotting components
US8567609B2 (en) 2006-05-25 2013-10-29 Biomet Biologics, Llc Apparatus and method for separating and concentrating fluids containing multiple components
US8328024B2 (en) 2007-04-12 2012-12-11 Hanuman, Llc Buoy suspension fractionation system
JP5479319B2 (ja) 2007-04-12 2014-04-23 バイオメット・バイオロジックス・リミテッド・ライアビリティ・カンパニー ブイ式懸濁液分画システム
EP2567692B1 (en) 2008-02-27 2016-04-06 Biomet Biologics, LLC Use of a device for obtaining interleukin-1 receptor antagonist rich solutions
US8337711B2 (en) 2008-02-29 2012-12-25 Biomet Biologics, Llc System and process for separating a material
US8313954B2 (en) 2009-04-03 2012-11-20 Biomet Biologics, Llc All-in-one means of separating blood components
US9011800B2 (en) 2009-07-16 2015-04-21 Biomet Biologics, Llc Method and apparatus for separating biological materials
US8591391B2 (en) 2010-04-12 2013-11-26 Biomet Biologics, Llc Method and apparatus for separating a material
US9642956B2 (en) 2012-08-27 2017-05-09 Biomet Biologics, Llc Apparatus and method for separating and concentrating fluids containing multiple components
US10208095B2 (en) 2013-03-15 2019-02-19 Biomet Manufacturing, Llc Methods for making cytokine compositions from tissues using non-centrifugal methods
US9950035B2 (en) 2013-03-15 2018-04-24 Biomet Biologics, Llc Methods and non-immunogenic compositions for treating inflammatory disorders
US10143725B2 (en) 2013-03-15 2018-12-04 Biomet Biologics, Llc Treatment of pain using protein solutions
US20140271589A1 (en) 2013-03-15 2014-09-18 Biomet Biologics, Llc Treatment of collagen defects using protein solutions
US9895418B2 (en) 2013-03-15 2018-02-20 Biomet Biologics, Llc Treatment of peripheral vascular disease using protein solutions
US9550028B2 (en) 2014-05-06 2017-01-24 Biomet Biologics, LLC. Single step desiccating bead-in-syringe concentrating device

Also Published As

Publication number Publication date
CA2428055A1 (en) 2002-05-16
RU2003117016A (ru) 2004-12-10
CZ20031277A3 (cs) 2003-08-13
BR0115188A (pt) 2004-02-03
PL360410A1 (en) 2004-09-06
MXPA03004030A (es) 2004-02-12
HUP0301766A2 (hu) 2003-08-28
WO2002038610A1 (en) 2002-05-16
KR20030057545A (ko) 2003-07-04
EE200300218A (et) 2003-08-15
EP1332159A1 (en) 2003-08-06
HUP0301766A3 (en) 2005-12-28
IL155539A0 (en) 2003-11-23
NO20032048D0 (no) 2003-05-07
JP2004522707A (ja) 2004-07-29
AU2002214468A1 (en) 2002-05-21

Similar Documents

Publication Publication Date Title
NO20030012L (no) Fremgangsmåte for fremstilling av substituerte oktanoylamider
NO20032048L (no) Fremgangsmåte for fremstilling av latent antitrombin III
CY2007029I2 (el) Μεθοδος για την παρασκευη υποκατεστημενων οκτανοϋλ-αμιδιων
NO20013942L (no) Fremgangsmate for fremstilling av Citalopram
FI20011541A0 (fi) Menetelmä massan valmistamiseksi
NO20032731D0 (no) Fremgangsmåte for fremstilling av sulfonamid-substituerte imidazotriazinoner
NO20044814L (no) Fremgangsmate for fremstilling av combretastaniner
NO20031413D0 (no) Ny fremgangsmåte for fremstilling av oksabispidiner
NO20042640L (no) Fremgangsmate for fremstilling av ekinocandinderivater
ID26097A (id) Proses pembuatan pakaian luar sekali pakai
NO20030515L (no) Fremgangsmåte for fremstilling av dinapsolin
NO20035538D0 (no) Fremgangsmåte for fremstilling av zaleplon
NO20025423L (no) Fremgangsmate for fremstilling av Citalopram
NO20026155L (no) Fremgangsmåte for fremstilling av lavere olefiner
NO20021118D0 (no) Fremgangsmåte for fremstilling av citalopram
DK1203000T3 (da) Fremgangsmåde til fremstilling af phosphonomethylglycin
NO20025465L (no) Fremgangsmåte for fremstilling av bifenylforbindelser
NO20024887L (no) FremgangsmÕte for fremstilling av benzokondenserte heterosykliske forbindelser
NO20023702D0 (no) Fremgangsmåte for fremstilling av 5-arylnikotinaldehyder
NO20025385L (no) Fremgangsmate for fremstilling av sulfonylbenzoylguanidiniumsalter
NO20035138D0 (no) Fremgangsmåte til fremstilling av amorft natriumsilastatin
NO20012811D0 (no) Fremgangsmåte for fremstilling av p-klorfenyl-propanol- derivat
NO20020328D0 (no) Fremgangsmåte for fremstilling av 4-cyano-2-aminometyltiazol
NO20013044D0 (no) Fremgangsmåte for fremstilling av NG-substituerte deaza- adenosinderivater
NO20020327D0 (no) Fremgangsmåte for fremstilling av 2-aminometyl-4-cyano-tiazol

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application